甲状腺毒症中的骨骼疾病。
Bone disease in thyrotoxicosis.
机构信息
Department of Endocrinology & Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
出版信息
Indian J Med Res. 2012 Mar;135(3):277-86.
Abstract
Thyrotoxicosis, a clinical syndrome characterized by manifestations of excess thyroid hormone, is one of the commonly-recognised conditions of the thyroid gland. Thyrotoxicosis causes acceleration of bone remodelling and though it is one of the known risk factors for osteoporosis, the metabolic effects of thyroxine on bone are not well discussed. Studies show that thyroid hormones have effects on bone, both in vitro and in vivo. Treatment of thyrotoxicosis leads to reversal of bone loss and metabolic alterations, and decreases the fracture risk. There are limited studies in India as to whether these changes are fully reversible. In this review we discuss about the effects of thyrotoxicosis (endogenous and exogenous) on bone and mineral metabolism, effects of subclinical thyrotoxicosis on bone and mineral metabolism and effects of various forms of treatment in improving the bone mineral density in thyrotoxicosis.
摘要
甲状腺功能亢进症，一种以甲状腺激素过度表现为特征的临床综合征，是甲状腺常见疾病之一。甲状腺功能亢进症导致骨重塑加速，尽管它是骨质疏松症的已知危险因素之一，但甲状腺素对骨的代谢作用尚未得到充分讨论。研究表明，甲状腺激素对骨具有体外和体内作用。甲状腺功能亢进症的治疗可逆转骨丢失和代谢改变，并降低骨折风险。印度关于这些变化是否完全可逆的研究有限。在这篇综述中，我们讨论了甲状腺功能亢进症（内源性和外源性）对骨和矿物质代谢的影响，亚临床甲状腺功能亢进症对骨和矿物质代谢的影响，以及各种治疗方法在改善甲状腺功能亢进症患者骨密度方面的作用。
相似文献
1
Bone disease in thyrotoxicosis.甲状腺毒症中的骨骼疾病。
Indian J Med Res. 2012 Mar;135(3):277-86.
2
The skeletal consequences of thyrotoxicosis.甲状腺毒症的骨骼后果。
J Endocrinol. 2012 Jun;213(3):209-21. doi: 10.1530/JOE-12-0059. Epub 2012 Mar 27.
3
Thyroid diseases and bone health.甲状腺疾病与骨骼健康。
J Endocrinol Invest. 2018 Jan;41(1):99-109. doi: 10.1007/s40618-017-0753-4. Epub 2017 Aug 29.
4
[The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].[甲状腺毒症及甲状腺素治疗对骨质疏松症风险的影响]
Pol Merkur Lekarski. 2000 May;8(47):356-9.
5
The multiple effects of thyroid disorders on bone and mineral metabolism.甲状腺疾病对骨骼和矿物质代谢的多重影响。
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):452-63. doi: 10.1590/0004-2730000003311.
6
[Bone changes in thyrotoxicosis].[甲状腺毒症中的骨骼变化]
Nihon Rinsho. 1998 Jun;56(6):1587-90.
7
Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.甲状腺毒症涉及β2-肾上腺素能受体信号传导，从而对股骨的微观结构和生物力学特性产生负面影响。
Thyroid. 2019 Aug;29(8):1060-1072. doi: 10.1089/thy.2018.0259.
8
[Osteoporosis treatment in patients with hyperthyroidism].[甲状腺功能亢进症患者的骨质疏松症治疗]
Nihon Rinsho. 2009 May;67(5):1011-6.
9
A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.仅采用促甲状腺激素抑制治疗甲状腺毒症的临床与治疗方法。
Am J Med. 2005 Apr;118(4):349-61. doi: 10.1016/j.amjmed.2005.01.004.
10
A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice.白细胞介素-6在小鼠甲状腺毒症相关骨转换紊乱发病机制中的关键作用。
Horm Metab Res. 2007 Dec;39(12):884-8. doi: 10.1055/s-2007-992776. Epub 2007 Oct 31.
引用本文的文献
1
Visfatin (rs3801266) and Adiponutrin (rs738409) gene single nucleotide polymorphisms in patients with Hashimoto's thyroiditis.桥本甲状腺炎患者中内脂素（rs3801266）和脂肪营养蛋白（rs738409）基因单核苷酸多态性
Mol Biol Rep. 2025 Apr 9;52(1):376. doi: 10.1007/s11033-025-10437-y.
2
Radiomorphometric Parameters in Mandibular Panoramic Radiographs of Hypothyroid Patients: A Cross-Sectional Study.甲状腺功能减退患者下颌全景片中的放射形态计量学参数：一项横断面研究。
Clin Cosmet Investig Dent. 2025 Jan 14;17:31-37. doi: 10.2147/CCIDE.S502528. eCollection 2025.
3
foxe1 mutant zebrafish show indications of a hypothyroid phenotype and increased sensitivity to ethanol for craniofacial malformations.foxe1突变斑马鱼表现出甲状腺功能减退表型的迹象，并且对乙醇诱导的颅面畸形敏感性增加。
Dev Dyn. 2025 Mar;254(3):240-256. doi: 10.1002/dvdy.745. Epub 2024 Oct 3.
4
The impact of thyroid function on total spine bone mineral density in postmenopausal women.甲状腺功能对绝经后女性全脊柱骨密度的影响。
Endocrine. 2024 Jul;85(1):279-286. doi: 10.1007/s12020-024-03712-8. Epub 2024 Feb 3.
5
Bone microarchitecture and bone mineral density in Graves' disease.格雷夫斯病中的骨微结构和骨矿物质密度
Osteoporos Sarcopenia. 2023 Jun;9(2):70-75. doi: 10.1016/j.afos.2023.05.001. Epub 2023 Jun 1.
6
Is thyroid disease associated with post-operative complications after total joint arthroplasty? A systematic review of the literature.甲状腺疾病与全关节置换术后的术后并发症有关吗？文献系统综述。
EFORT Open Rev. 2023 Feb 21;8(2):54-62. doi: 10.1530/EOR-22-0085.
7
Cardiovascular Involvement in Thyrotoxicosis Resulting in Heart Failure: The Risk Factors and Hemodynamic Implications.甲状腺毒症所致心血管受累导致心力衰竭：危险因素及血流动力学影响
Cureus. 2022 Jan 13;14(1):e21213. doi: 10.7759/cureus.21213. eCollection 2022 Jan.
8
Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection.SARS-CoV-2 感染后亚急性甲状腺炎的成功治疗。
Intern Med. 2021 Nov 15;60(22):3573-3576. doi: 10.2169/internalmedicine.7913-21. Epub 2021 Sep 11.
9
Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review.维生素 D 缺乏症、骨质疏松症及其对自身免疫性疾病和造血的影响：综述。
Int J Mol Sci. 2021 Aug 17;22(16):8855. doi: 10.3390/ijms22168855.
10
Prevalence and risk factors for osteoporotic fracture among adults with comorbidities in Al-Ahsaa, Saudi Arabia.沙特阿拉伯东部省患有合并症的成年人骨质疏松性骨折的患病率及危险因素
J Family Med Prim Care. 2020 Feb 28;9(2):877-882. doi: 10.4103/jfmpc.jfmpc_982_19. eCollection 2020 Feb.
本文引用的文献
1
Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism.甲状腺功能亢进症中的维生素 D 缺乏症与骨代谢和骨密度。
J Clin Densitom. 2010 Oct-Dec;13(4):462-6. doi: 10.1016/j.jocd.2010.05.008. Epub 2010 Jul 21.
2
Hypokalemic periodic paralysis associated with thyrotoxicosis, renal tubular acidosis and nephrogenic diabetes insipidus.与甲状腺毒症、肾小管性酸中毒和肾性尿崩症相关的低钾性周期性瘫痪。
Endocr J. 2010;57(4):347-50. doi: 10.1507/endocrj.k09e-261. Epub 2010 Feb 11.
3
Vitamin D status in India--its implications and remedial measures.印度的维生素D状况——其影响及补救措施
J Assoc Physicians India. 2009 Jan;57:40-8.
4
Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study.血清 TSH 和 FT4 水平及 TSHR-Asp727Glu 多态性对骨的影响：鹿特丹研究。
Clin Endocrinol (Oxf). 2008 Feb;68(2):175-81. doi: 10.1111/j.1365-2265.2007.03016.x. Epub 2007 Sep 4.
5
The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.成纤维细胞生长因子23（FGF-23）在格雷夫斯病中对矿物质代谢变化的适应性及关系
Clin Endocrinol (Oxf). 2007 Jun;66(6):854-8. doi: 10.1111/j.1365-2265.2007.02824.x. Epub 2007 Apr 15.
6
High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians.健康的南印度人膳食钙含量低、植酸摄入量高和维生素D缺乏的情况普遍存在。
Am J Clin Nutr. 2007 Apr;85(4):1062-7. doi: 10.1093/ajcn/85.4.1062.
7
Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism.甲状腺功能亢进症中，是甲状腺激素过多而非促甲状腺激素缺乏导致骨质疏松。
Mol Endocrinol. 2007 May;21(5):1095-107. doi: 10.1210/me.2007-0033. Epub 2007 Feb 27.
8
Evaluation of bone mineral density in thyrotoxicosis.甲状腺毒症患者骨密度的评估
Singapore Med J. 2006 Nov;47(11):947-50.
9
Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women.在健康的绝经后女性中，促甲状腺激素（TSH）水平略低于正常范围与骨矿物质密度较低有关。
Clin Endocrinol (Oxf). 2006 Jan;64(1):86-90. doi: 10.1111/j.1365-2265.2005.02422.x.
10
Bone mineral density in hyperthyroidism.甲状腺功能亢进症中的骨矿物质密度
Clin Endocrinol (Oxf). 2004 Oct;61(4):466-72. doi: 10.1111/j.1365-2265.2004.02110.x.
Zotero 插件